Karina Kapusta

Dr. Karina Kapusta

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2020 in Molecules
Verified
Journal Article
Open access
PDF file
MSMaciej Spiegel
Maciej Spiegel
KKKarina Kapusta
Karina Kapusta
WKWojciech Kolodziejczyk
Wojciech Kolodziejczyk
JSJulia Saloni
Julia Saloni
BŻBeata Żbikowska
Beata Żbikowska
ZSZbigniew Sroka
Zbigniew Sroka
Phenolic acids are naturally occurring compounds that are known for their antioxidant and antiradical activity. We present experimental and theoretical studies on the antioxidant potential of the set of 22 phenolic acids with different models of hydroxylation and methoxylation of aromatic rings. Ferric reducing antioxidant power assay was used to evaluate this property. 2,3-dihydroxybenzoic acid was found to be the strongest antioxidant, while mono hydroxylated and methoxylated structures had the lowest activities. A comprehensive structure–activity investigation with density functional theory methods elucidated the influence of compounds topology, resonance stabilization, and intramolecular hydrogen bonding on the exhibited activity. The key factor was found to be a presence of two or more hydroxyl groups being located in ortho or para position to each other. Finally, the quantitative structure–activity relationship approach was used to build a multiple linear regression model describing the dependence of antioxidant activity on structure of compounds, using features exclusively related to their topology. Coefficients of determination for training set and for the test set equaled 0.9918 and 0.9993 respectively, and Q2 value for leave-one-out was 0.9716. In addition, the presented model was used to predict activities of phenolic acids that haven’t been tested here experimentally.

14 August 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
KKKarina Kapusta
Karina Kapusta
Supratik KarSupratik Kar
Supratik Kar
JCJasmine T. Collins
Jasmine T. Collins
LFLatasha M. Franklin
Latasha M. Franklin
WKWojciech Kolodziejczyk
Wojciech Kolodziejczyk
GHGlake Hill
Glake Hill
Due to an outbreak of COVID-19, the number of research papers devoted to in-silico drug discovery of potential antiviral drugs is increasing every day exponentially. Still, there is no specific drug to prevent or treat this novel coronavirus (SARS-CoV-2) disease. Thus, the screening for a potential remedy presents a global challenge for scientists. Up to date over a hundred crystallographic structures of SARS-CoV-2 Mpro have been deposited to Protein Data Bank. With many known proteins, the demand for a reliable target has become higher than ever, so as the choice of an efficient computational methods. Therefore, in this study comparative methods have been used for receptor-based virtual screening, targeting 9 selected structures of viral Mpro. Reliability analyses followed by re-docking of the specific co-crystallized ligand provided the best reproductivity for structures with PDB ID 6LU7, 6Y2G and 6Y2F. The influence of crystallographic water on an outcome of a virtual screening against selected targets was also investigated. Once the most reliable targets were selected, the library of easy purchasable natural compounds were retrieved from the MolPort database (10,305 compounds) and docked against the selected Mpro proteins. To ensure the efficiency of the selected compounds, binding energies for top-15 hit ligands were calculated using Molecular Mechanics as well as their absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties were predicted. Based on predicted binding energies and toxicities, top-5 compounds were selected and subjected to Molecular Dynamics simulation and found to be stable in complex to act as possible inhibitors for SARS-CoV-2. Communicated by Ramaswamy H. Sarma

17 February 2018 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
KKKarina Kapusta
Karina Kapusta
NSNatalia Sizochenko
Natalia Sizochenko
SKSedat Karabulut
Sedat Karabulut
Sergiy OkovytyySergiy Okovytyy
Sergiy Okovytyy
EVEugene Voronkov
Eugene Voronkov
JLJerzy Leszczynski
Jerzy Leszczynski

1 December 2018 in Russian Journal of Physical Chemistry A
Verified
Journal Article
Closed access
PDF file
KKKarina Kapusta
Karina Kapusta
EVE. Voronkov
E. Voronkov
SOS. Okovytyy
S. Okovytyy
VKV. Korobov
V. Korobov
JLJ. Leszczynski
J. Leszczynski
The new approach for the determination of orbital exponents and contracted coefficients for STO-3G family basis sets has been proposed. Calculations of the necessary coefficients have been...

28 July 2023 in Langmuir
Verified
Journal Article
Closed access
DDDonovan S. Darlington
Donovan S. Darlington
AMAllison N. Mahurin
Allison N. Mahurin
KKKarina Kapusta
Karina Kapusta
ESEmber Suh
Ember Suh
CSCameron Smith
Cameron Smith
ETEden E. L. Tanner
Eden E. L. Tanner

21 September 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
OOOlabimpe Olafuyi
Olabimpe Olafuyi
KKKarina Kapusta
Karina Kapusta
ARAlexander Reed
Alexander Reed
WKWojciech Kolodziejczyk
Wojciech Kolodziejczyk
JSJulia Saloni
Julia Saloni
GHGlake A. Hill
Glake A. Hill
Even though the vast armamentarium of FDA-approved antiepileptic drugs is currently available, over one-third of patients do not respond to medication, which arises a need for alternative medicine. In clinical and preclinical studies, various investigations have shown the advantage of specific plant-based cannabidiol (CBD) products in treating certain groups of people with limbic epilepsy who have failed to respond to conventional therapies. This work aims to investigate possible mechanisms by which CBD possesses its anticonvulsant properties. Molecular targets for CBD’s treatment of limbic epilepsy, including hyperpolarization-activated cyclic nucleotide-gated channel 1 (HCN1), gamma-aminobutyric acid aminotransferase (GABA-AT), and gamma-aminobutyric acid type A receptor (GABAA), were used to evaluate its binding affinity. Interactions with the CB1 receptor were initially modeled as a benchmark, which further proved the efficiency of proposed here approach. Considering the successful benchmark, we further used the same concept for in silico investigation, targeting proteins of interest. As a result of molecular docking, molecular mechanics, and molecular dynamics simulations models of CBD-receptor complexes were proposed and evaluated. While CBD possessed decently high affinity and stability within the binding pockets of GABA-AT and some binding sites of GABAA, the most effective binding was observed in the CBD complex with HCN1 receptor. 100 ns molecular dynamics simulation revealed that CBD binds the open pore of HCN1 receptor, forming a similar pattern of interactions as potent Lamotrigine. Therefore, we can propose that HCN1 can serve as a most potent target for cannabinoid antiepileptic treatment. Communicated by Ramaswamy H. Sarma Graphical Abstract